Evidence based patient guide. 7 to 9 minute read.
By RealMedVision
The most famous weight loss injection in the world now comes as a daily tablet. The catch is simple. You cannot buy it in India yet.
Note:
The Wegovy pill contains oral semaglutide 25 mg. Novo Nordisk makes it, the same company behind the Wegovy injection, Ozempic and Rybelsus, all built on the same molecule.
Quick answer
- The Wegovy pill is a once daily oral semaglutide 25 mg tablet for weight loss, approved in the United States on 22 December 2025.
- It launched in the US in January 2026 at 149 to 299 dollars a month, and Europe approved it in July 2026.
- The Wegovy pill in India has no approval, no price and no launch date yet.
- Rybelsus and its Indian generics are a different dose of the same molecule, approved here only for type 2 diabetes.
- In its main trial, people who started the pill lost 13.6 percent of body weight over 64 weeks.
Every clinic conversation about weight loss injections ends with the same question. Is there a tablet instead? Since January 2026, America has one. Novo Nordisk sells the Wegovy pill there, a once daily tablet carrying the same medicine as the famous weekly injection. For anyone searching for the Wegovy pill in India, the answer is shorter. It has not arrived, and no Indian price exists.
What is the Wegovy pill?
The Wegovy pill is oral semaglutide at a 25 mg dose, taken once a day for long-term weight management. The US Food and Drug Administration cleared it on 22 December 2025 as the first oral GLP-1 medicine approved in the US for weight loss. It is meant for adults with obesity, or adults who are overweight and have at least one weight-related health problem, always alongside a lower calorie diet and more activity.
Semaglutide copies GLP-1, a gut hormone your body releases after meals. It tells the pancreas to release insulin, signals the brain that you are full, and slows how fast the stomach empties. Appetite falls, portions shrink, and weight comes down over months. The pill does this job without a needle.
Is the Wegovy pill available in India?
No. As of August 2026 there is no Wegovy pill in India through any pharmacy, hospital or online platform. It is on sale in the United States, the UK and the UAE, so treat any website claiming to sell it here with caution, because the product is not approved for marketing in India.
Current regulatory status
Novo Nordisk submitted the 25 mg formulation to European regulators in late 2025, and the European Commission approved the Wegovy pill on 15 July 2026, its fifth approval after the US, the UK, the UAE and Bahrain. For India, no CDSCO approval or expert committee recommendation for the tablet was found in the public records reviewed for this article, which places the pill a step behind its main rival. Eli Lilly’s orforglipron already holds a CDSCO expert panel recommendation from May 2026, with the final decision awaited. [orforglipron tablet price in India]
Two ways the pill could reach Indian patients
The first route is a direct Novo Nordisk launch after Indian approval, the path the Wegovy injection took in June 2025. [Wegovy injection price in India] The second route is specific to India. Semaglutide went off patent here in March 2026, and more than 40 companies already sell generic injections. Nothing stops an Indian maker from seeking approval for its own 25 mg oral version. Neither route has a confirmed date, so treat every launch claim as a rumour until Novo Nordisk or the regulator speaks. [semaglutide brands in India]
When will the Wegovy pill launch in India?
There is no confirmed India launch date. Novo Nordisk says it plans to take the pill to more countries in the second half of 2026, but it has named no timeline for India, and no CDSCO approval for Wegovy tablets was identified in the public records reviewed for this article. Ignore any website quoting a specific month or year until the company or CDSCO announces it officially.
Wegovy pill price in India and the US
Since no Indian launch exists, no genuine Wegovy pill price in India exists either. The US price is the only official benchmark, and Novo Nordisk publishes it for self-paying patients through its own pharmacy and partner chemists.
| Wegovy pill dose | US self-pay price per month |
|---|---|
| 1.5 mg, starting dose | About 149 dollars |
| 4 mg | About 149 dollars at launch, about 199 dollars from mid April 2026 |
| 9 mg | About 299 dollars |
| 25 mg, full dose | About 299 dollars |
Prices are US self pay figures from 2026 and can change. Insurance in the US lowers them further for eligible patients.
What would it cost here? Indian prices usually land far below American ones. The Wegovy injection sells here for roughly Rs 10,850 to Rs 16,400 a month after its 2025 cut, with further reductions reported through 2026, and generic semaglutide injections start near Rs 1,300. A launched pill would have to price against that reality, and until an MRP is announced, every rupee figure you see online for it is invented. [Ozempic price in India]
Keep in Mind
Because the pill is not approved for marketing in India, treat any listing that claims to sell the Wegovy pill in India today with caution. Such stock can only involve unapproved imports or fake tablets. Wait for an official launch, then buy only from a licensed pharmacy with a valid prescription.
How much weight can you lose on the Wegovy pill?
The approval rests on OASIS 4, a 64 week trial in adults with obesity, or overweight plus a weight related condition, without diabetes. Counting everyone who started the tablet, average weight loss was 13.6 percent, against 2.2 percent with placebo. Among people who stayed on treatment as prescribed, the average reached 16.6 percent. Waist size, blood sugar and several heart risk markers improved as well.
Numbers like these describe averages, not promises. Some participants lost a fifth of their body weight, others lost far less, and side effects led a portion to stop early. Your own result depends on dose tolerance, diet, activity and how long you stay on treatment.
How to take the Wegovy pill
Dosing starts low and climbs in steps, a process called titration that gives your stomach time to adjust. Treatment begins at 1.5 mg once daily for the first 30 days, moves to 4 mg for the next 30, then steps up through 9 mg as tolerated until the 25 mg maintenance dose.
The routine matters as much as the dose. The pill holds 25 mg against the injection’s weekly 2.4 mg because the gut destroys most of a swallowed peptide, so conditions must be right. Take the tablet on an empty stomach after waking, with up to 120 ml of plain water, then wait at least 30 minutes before any food, beverages or other oral medicines. Skip that discipline and absorption drops sharply.
Doctor’s Tip
Anchor the tablet to a fixed morning habit. Keep it by the bed, take it the moment you wake, and let your morning tea mark the end of the 30 minute wait. Build this rhythm in week one and you will rarely miss the window.
This is the US approved plan, shared for information only. Your doctor decides your dose, your pace and whether a pill or an injection suits you better. Never adjust a GLP-1 dose on your own. The once weekly convenience trend now runs through diabetes care as well, led by weekly basal insulin.
[Awiqli once weekly insulin price in India]
Wegovy pill vs Wegovy injection
Neither form is simply better. They trade convenience in different directions.
| Feature | Wegovy pill | Wegovy injection |
|---|---|---|
| Form and schedule | Tablet, once daily | Injection, once weekly |
| Food rules | Empty stomach, wait before eating | No food timing rules |
| Storage | Room temperature | Normally refrigerated, limited room temperature storage allowed on the label |
| Average weight loss | Similar to the injection | Similar to the pill |
| Available in India | Not launched | Yes, since June 2025 |
For Indian patients the last row settles it for now. The injection, its cheaper generic rivals and Mounjaro are the options that actually exist on chemist shelves today. Our comparison of the two leading injections walks through that choice. [Mounjaro vs Ozempic in India]
Wegovy pill vs Rybelsus vs orforglipron
Three weight-related tablets now share headlines, and mixing them up is easy. One is a diabetes dose of oral semaglutide, one is the weight loss dose, and one is a different molecule built to survive digestion.
| Tablet | What it is | Approved use | India status, August 2026 |
|---|---|---|---|
| Wegovy pill | Oral semaglutide 25 mg | Weight loss | Not launched, no approval on record |
| Rybelsus and its generics | Oral semaglutide, lower diabetes doses | Type 2 diabetes | Available for diabetes only |
| Orforglipron | Non-peptide oral GLP-1 | Weight loss, US approved | Expert panel nod, final approval awaited |
Good to Know
Oral semaglutide sold in India today, whether branded Rybelsus or generic, comes at much lower diabetes strength doses and is approved here for type 2 diabetes rather than weight loss. Taking a diabetes dose and expecting Wegovy pill results sets you up for disappointment, and using any prescription tablet off label without medical supervision is unsafe.
For Indian readers, the real race is between Novo Nordisk and Eli Lilly. Orforglipron can be taken at any time of day with or without food, while the Wegovy pill demands the empty stomach routine. The first oral GLP-1 to receive Indian approval could become an important option for weight management here. [Rybelsus generic in India]
Side effects and who should avoid it
Stomach and gut reactions lead the list, exactly as with every GLP-1 medicine. Nausea, vomiting, diarrhoea, constipation and reduced appetite are most common, peaking when a dose rises and usually easing within weeks. Smaller meals, less oily food and steady hydration carry most people through the early phase.
Serious risks are rarer but firm. In the US, the label carries a boxed warning for thyroid C cell tumours seen in rodent studies, so anyone with a personal or family history of medullary thyroid cancer or MEN 2 should not take it. It is not advised in pregnancy, and anyone breastfeeding or planning a pregnancy should discuss timing with their doctor first, since the prescribing information carries specific guidance there. People with a history of pancreatitis and anyone under 18 should also avoid it. Share your full medical history and every current medicine before starting any semaglutide product.
When to Call Your Doctor:
Get medical help quickly for severe or lasting stomach pain, especially pain spreading to the back, which can signal pancreatitis. Do the same for a lump or swelling in the neck, a hoarse voice, trouble swallowing, dehydration from repeated vomiting, or signs of low blood sugar such as shaking, sweating and confusion if you also take diabetes medicines.
A common clinic conversation
Illustrative example, not a real patient. Meera, 41, from Pune, shows her physician an Instagram post about the new weight loss tablet and asks for a prescription. Her doctor explains that it has not launched in India, that the semaglutide tablets sold here are diabetes doses, and that her real options today are the approved injections. She leaves without the tablet, but also without spending Rs 15,000 on a fake one. That trade is the point of asking first.
Key takeaways
- Ask your doctor about currently approved options, since the Wegovy pill cannot be legally prescribed in India yet.
- Treat any Indian website selling the pill today as a red flag, not a shortcut.
- Watch for a CDSCO approval or an official Novo Nordisk announcement before believing any launch date or price.
- Remember the empty stomach rule wherever you start the pill, because absorption depends on it.
- Do not substitute diabetes dose semaglutide tablets for weight loss on your own.
Bottom line
The Wegovy pill has shown substantial weight loss in clinical trials, giving patients a daily oral alternative to injectable treatment. For now it is a preview here, not a product. No approval exists, rival orforglipron sits a step ahead in the queue, and India’s generic makers add a wildcard no other market has. This page tracks the Wegovy pill in India as the story unfolds, so check back after any big announcement. Until then, your doctor, not a reseller, is the right guide to what you can start today.
Medical disclaimer
This article is for general information only and is not medical advice. The Wegovy pill, semaglutide injections and related medicines are prescription products. Do not start, stop or change any weight loss or diabetes medicine without speaking to a qualified doctor. Prices and availability are based on public information from 2026 and can change.
Frequently asked questions
Is the Wegovy pill available in India?
Not yet. As of August 2026 the pill is on sale in the United States, the UK and the UAE, while India has no approval or launch date on record. Beware of any Indian seller claiming to stock it today.
What is the Wegovy pill price in India?
No Indian price exists because the pill has not launched here. In the US it costs about 149 to 299 dollars a month depending on the dose, and Indian prices for similar medicines usually land far lower once official launches happen.
How much does the Wegovy pill cost per month in the US?
Self paying patients start at about 149 dollars a month for the lowest dose, while the 9 mg and 25 mg doses cost about 299 dollars a month. Insurance can reduce these amounts for eligible Americans.
Is the Wegovy pill the same as Rybelsus?
Same molecule, different product, dose and approved use. Rybelsus comes in 3, 7 and 14 mg strengths, and in India it and its generic versions are approved for type 2 diabetes, while the Wegovy pill is a 25 mg dose approved for weight loss.
How much weight can you lose on the Wegovy pill?
In the OASIS 4 trial, everyone who started the tablet lost 13.6 percent of body weight on average over 64 weeks, and those who stayed on treatment averaged 16.6 percent. Individual results varied widely.
Is the Wegovy pill better than the Wegovy injection?
It works about as well, not better. Novo Nordisk reports similar average weight loss for both forms, so the choice comes down to a daily tablet with food timing rules versus a weekly injection kept in the fridge.
How is the Wegovy pill different from orforglipron?
Orforglipron is a non peptide molecule from Eli Lilly that can be taken any time with or without food, while the Wegovy pill is a peptide that needs an empty stomach. In India, orforglipron already has an expert panel recommendation and the Wegovy pill does not.
Can I buy the Wegovy pill online in India?
No approved Wegovy tablet is marketed in India right now, so genuine stock cannot exist on any Indian website. Avoid sellers offering imported or unverified tablets, and wait for an official launch through licensed pharmacies.
What are the side effects of the Wegovy pill?
Nausea, vomiting, diarrhoea, constipation and reduced appetite are the most common effects, mainly during dose increases. Rare but serious risks include pancreatitis and a boxed warning for thyroid C cell tumours, so medical supervision is essential.
References
- DailyMed, 2026, Wegovy oral semaglutide tablets prescribing information
- Novo Nordisk, 2025, FDA approval of the Wegovy pill, oral semaglutide 25 mg
- Novo Nordisk, 2026, European Commission approval of the Wegovy pill
- New England Journal of Medicine, 2025, OASIS 4 trial of oral semaglutide 25 mg in overweight and obesity
- CNBC, 2026, US launch and pricing of the Wegovy pill
- Medical Dialogues, 2026, CDSCO panel recommendation for orforglipron tablets
- CNBC, 2026, semaglutide generics launch in India after patent expiry
- eMarketer, 2026, generic semaglutide market share in India
Medically reviewed by
This guide was checked for medical accuracy by our review board before publishing.
Dr. Praveen Verma, MBBS, MD (Pathology), Pathologist and Clinical Laboratory Specialist.
Dr. Himanshu Morya, MBBS, Medical Educator.
About the author
Iraphan Khan, BSN, RN, D.Pharm is the founder of RealMedVision and a Public Health Researcher who creates evidence-based health content from trusted medical sources.